Compare STTK & FOXF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STTK | FOXF |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Motor Vehicles |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 792.9M | 800.6M |
| IPO Year | 2020 | 2013 |
| Metric | STTK | FOXF |
|---|---|---|
| Price | $6.85 | $21.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | $10.00 | ★ $30.25 |
| AVG Volume (30 Days) | ★ 773.5K | 533.7K |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.02 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,000,000.00 | ★ $1,467,321,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.90 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.27 |
| 52 Week Low | $1.59 | $13.08 |
| 52 Week High | $8.33 | $29.97 |
| Indicator | STTK | FOXF |
|---|---|---|
| Relative Strength Index (RSI) | 44.39 | 51.90 |
| Support Level | $5.87 | $20.39 |
| Resistance Level | $7.75 | $20.98 |
| Average True Range (ATR) | 0.34 | 0.62 |
| MACD | -0.12 | -0.22 |
| Stochastic Oscillator | 11.51 | 31.33 |
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
Fox Factory Holding Corp is a designer, manufacturer, and marketer of performance-defining products and systems used predominantly on bikes, Side-by-Sides, on-road vehicles with and without off-road capabilities, off-road vehicles and trucks, ATVs, snowmobiles, specialty vehicles and applications, motorcycles, and commercial trucks. Its business operates under the FOX, FOX RACING SHOX, and RACE FACE brands. Geographically, it derives a majority of revenue from North America and also has a presence in Asia, Europe, and the Rest of the World. The company operates in three segments: Powered Vehicles Group, Aftermarket Applications Group, and Specialty Sports Group, of which it derives maximum revenue from Specialty Sports Group segment.